SCHEMBL1704450

SCHEMBL1704450

Cc1ccc(NC(=O)c2sccc2N(C(=O)O)C(C)(C)C)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.49
NPC1 O15118 7/20 0.46
RAB9A P51151 7/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
EDNRB P24530 3/20 0.44
EDNRA P25101 3/20 0.44
MAPT P10636 2/20 0.43
ATM Q13315 1/20 0.43
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
LMNA P02545 2/20 0.42
KDM4E B2RXH2 1/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
F10 P00742 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
ALPG P10696 1/20 0.42
CYP2C9 P11712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1703670 0.89 PKM (0.45) PKMNPC1RAB9ASMN1; SMN2EDNRB
SCHEMBL1704052 0.85 ALDH1A1 (0.49) PKMNPC1RAB9ASMN1; SMN2EDNRB
SCHEMBL1703757 0.80 HPGD (0.48) NPC1RAB9ASMN1; SMN2EDNRAMAPT
SCHEMBL1703824 0.78 RAB9A (0.55) PKMNPC1RAB9ASMN1; SMN2MAPT
SCHEMBL5790071 0.78 KIT (0.48) PKMNPC1RAB9ASMN1; SMN2MAPT
SCHEMBL17664660 0.75 PKM (0.74) PKMNPC1RAB9ASMN1; SMN2MAPT
SCHEMBL1704103 0.75 RAB9A (0.60) PKMNPC1RAB9ASMN1; SMN2EDNRB
SCHEMBL1703373 0.73 NPC1 (0.56) PKMNPC1RAB9ASMN1; SMN2EDNRB
SCHEMBL27496628 0.71 EDNRA (0.58) PKMNPC1RAB9ASMN1; SMN2EDNRB
SCHEMBL17440276 0.70 LMNA (0.35) LMNAKDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2441768-A1 Thienopyrimidinones for treatment of inflammatory disorders and cancers Eli Lilly & Co. (US) 2012-04-18 EP disclosed